Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00962494 · ClinicalTrials.gov registry record · Phase 2

Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors

A Phase 2 study, sponsored by Stanford University.

Completed
Registry status
Phase 2
Development phase
585
Enrollment target

NCT00962494: Completed Phase 2 study, sponsored by Stanford University.

NCT00962494 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 585 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00962494, a Phase 2 study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 2
Development phase
585 participants
Enrollment target

Study Summary

Cancer: Surviving and Thriving is a 6-week workshop for cancer survivors. The overall goal of the study is to determine whether an online cancer survivor education and support workshop can have lasting beneficial effects in helping survivors improve their self-management of health skills and quality of life.

Interventions

  • BEHAVIORAL Cancer: Thriving and Surviving Online Workshop

Trial Details

FieldValue
Enrollment Target 585 participants
Start Date 2009-07
Est. Completion 2011-12
Phase Phase 2

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00962494

The ClinicalTrials.gov registry entry for NCT00962494 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 585 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cancer: Thriving and Surviving Online Workshop is the first listed.

NCT00962494 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00962494 about?

NCT00962494 is a clinical study titled "Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors". Cancer: Surviving and Thriving is a 6-week workshop for cancer survivors. The overall goal of the study is to determine whether an online cancer survivor education and support workshop can have lasting beneficial effects in helping survivors improve their self-management of health skills and quality...

What is the current status of trial NCT00962494?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 585 participants. The study started on 2009-07. Estimated completion is 2011-12.

What interventions are being tested in trial NCT00962494?

The interventions under investigation include: Cancer: Thriving and Surviving Online Workshop (BEHAVIORAL).

Who is sponsoring clinical trial NCT00962494?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.